DJIA 17,678.70 6.10 0.03%
NASDAQ 4,771.76 13.88 0.29%
S&P 500 2,057.09 5.27 0.26%
market minute promo

159.86 0.20 (0.13%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VRX $159.86 0.13%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $160.05
Previous Close $159.66
Daily Range $159.16 - $160.99
52-Week Range $106.00 - $160.99
Market Cap $53.7B
P/E Ratio 103.68
Dividend (Yield) $0.00 (0.0%)
Volume 1,652,740
Average Daily Volume 2,034,481
Current FY EPS $2.96

Sector

Healthcare

Industry

Drugs

Valeant Pharmaceuticals (VRX) Description

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology. Website: http://www.valeant.com/

News & Commentary Rss Feed

Top Pharmaceutical Stocks to Buy for 2015

Three fast-growing pharmaceutical stocks that investors may want to consider owning in 2015.

New Guru Jana Partners' Newest Stock Buys

A Look At Actavis

Valeant's Bausch + Lomb Imaging System Cleared by FDA - Analyst Blog

Why Valeant Pharmaceuticals (VRX) Isn't Done Growing Earnings Yet - Tale of the Tape

UPDATE: Morgan Stanley Reiterates, Raises Price Target On Valeant Pharmaceuticals As Jublia Formular

UPDATE: Morgan Stanley Reiterates, Raises Price Target On Valeant Pharmaceuticals As Jublia Formulary Concerns Are Noise

Valeant CEO On Allegations Against The Company And Future M&A Deals

New Lifetime High Today: Valeant Pharmaceuticals International (VRX)

Valeant Pharmaceuticals, A Bet The Jockey Story With Upside

Analysts Make Bullish Ratings in Response to Valeant's Increased 2015 Guidance

Valeant Up on Better-than-Expected 2015 Outlook, Eyes Deals - Analyst Blog

Valeant Up on Better-than-Expected 2015 Outlook, Eyes Deals - Analyst Blog

See More VRX News...

VRX's Top Competitors

VRX $159.86 (0.13%)
Current stock: VRX
NVS $96.49 (-0.39%)
Current stock: NVS
PFE $32.80 (1.08%)
Current stock: PFE
JNJ $102.26 (0.06%)
Current stock: JNJ